Brand-name vs compounded
Hers vs Yucca Health: Brand-Name or Compounded? (2026)
Compare Hers and Yucca Health on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 9.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both Hers and Yucca Health will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
The dividing line is regulatory, not cosmetic: Hers works with product the FDA has reviewed and approved, while Yucca Health runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Yucca Health — $1,752 against $1,788 at Hers, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- Yucca Health — Tirzepatide at $258/mo; the other side publishes semaglutide only.
- Most support included
- Hers — Personalized care team with ongoing dose check-ins.
The short version: Hers vs Yucca Health
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| Hers | Yucca Health | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | Semaglutide $146/mo, tirzepatide $258/mo |
| Rate after promotions | $149/mo | $146/mo |
| Pricing structure | Published rate per medication | Price locked for the life of the plan |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide and compounded tirzepatide |
| State coverage | Not published | All 50 states |
| How fast you start | Online intake with clinician review | Approval within 24 hours |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Klarna, Afterpay and Affirm |
| Patient reviews | 6,200 | 36,958 |
| eRxDoctor score | 9.8/10 | 9.5/10 |
What Hers and Yucca Health actually cost over a year
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Hers | Yucca Health | |
|---|---|---|
| First month | $149 | $146 |
| Months 2 onward | $149/mo | $146/mo |
| 6-month total | $894 | $876 |
| 12-month total | $1,788 | $1,752 |
| Best published plan | No multi-month discount published | 6-month semaglutide plan at $875 — $1,752/yr |
Over a year that is a $36 difference, in Yucca Health's favor. Whether it is the right call depends on whether Hers gives you $3 a month of something you will use.
What is actually in the vial
Hers supplies FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
Yucca Health works with compounded semaglutide and compounded tirzepatide. Compounding is what puts $146/mo within reach; it also means no approval application stands behind the specific product you receive.
The honest framing is a trade, not a ranking. Compounded access is what has put GLP-1 treatment within reach of people whose insurance will not cover it; approved product is what removes a category of uncertainty about what is in the vial. Both of those are real.
A closer look at Hers
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications.
The process is online intake with clinician review, then home delivery, no insurance required. On money, expect published rate per medication — published upfront.
Support: personalized care team with ongoing dose check-ins. The medications on offer are FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- Personalized care team with ongoing dose check-ins
- FDA-approved brand-name Wegovy®, not a compounded product
- No insurance required
Hers cons
- Higher starting price than most compounded competitors
- No compounded/generic alternative offered
Read next to Yucca Health, the weak point: there is no compounded tier to fall back on if the brand-name price stops working for you.
Yucca Health: what you are buying
Yucca Health positions itself on a price lock at $146 plus three buy-now-pay-later options, which is unusual at the bottom of the market. Yucca Health (TryYucca) review 2026: personalized compounded semaglutide from $146/month and tirzepatide from $258/month. Fast 24-hr approval, UPS 2-Day Air, Klarna/Affirm/Afterpay accepted.
Getting started means approval within 24 hours, after which UPS 2-Day Air from a licensed U.S. compounding pharmacy. Pricing runs on a price locked for the life of the plan basis, published upfront.
Ongoing care is personalized treatment plans from board-certified providers, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Yucca Health pros
- Fast 24-hour approval with fully online intake, no clinic visits required
- UPS 2-Day Air shipping on most orders from a licensed U.S. compounding pharmacy
- Personalized treatment plans based on your health history and weight loss goals
- Compounded semaglutide from $146/month, one of the lowest prices from a legitimate GLP-1 telehealth provider
Yucca Health cons
- Does not accept health insurance
- No branded FDA-approved medications (Ozempic, Wegovy, Zepbound)
- Cancellation terms for multi-month plans should be confirmed before purchase
The reservation worth holding, particularly next to Hers: no branded medication, no insurance billing and no outcome guarantee.
Picking between them
Choose Hers if:
- delivery works the way you want it to: home delivery, no insurance required
- you want to start on their timeline: online intake with clinician review
- the level of clinical contact suits you: personalized care team with ongoing dose check-ins
- the feature you would actually use: brand-name Wegovy at a price that usually buys compounded medication elsewhere
Choose Yucca Health if:
- the level of clinical contact suits you: personalized treatment plans from board-certified providers
- you would get real value from a price lock at $146 plus three buy-now-pay-later options, which is unusual at the bottom of the market
- you are in a state where GLP-1 telehealth coverage is patchy
- you would rather use the platform with the longer public record (36,958 reviews)
What each one gives up
On price. Yucca Health is the cheaper program at $146/mo against $149/mo. What Yucca Health gives up for that is no branded medication, no insurance billing and no outcome guarantee; what Hers charges for is brand-name Wegovy at a price that usually buys compounded medication elsewhere.
On commitment. Yucca Health rewards a longer commitment (6-month semaglutide plan at $875), which lowers the effective rate but ties up money before you know how you respond to the medication. Financing is available through Yucca Health (Klarna, Afterpay and Affirm).
On predictability. The pricing structures differ (published rate per medication versus price locked for the life of the plan), and structure, not headline rate, determines the twelve-month bill.
On access. Hers advertises online intake with clinician review and home delivery, no insurance required; Yucca Health advertises approval within 24 hours and UPS 2-Day Air from a licensed U.S. compounding pharmacy. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
What the evidence actually says
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The FDA approved tirzepatide for chronic weight management in November 2023, two years after semaglutide, per FDA.
In the STEP 1 trial, weekly semaglutide 2.4 mg produced a mean body-weight change of −14.9% at 68 weeks against −2.4% on placebo, per NEJM, STEP 1.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Hers vs Yucca Health: common questions
Which costs less over a year, Hers or Yucca Health?
Yucca Health, at roughly $1,752 for twelve months against $1,788 at Hers, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Yucca Health cheaper than Hers?
Yes, on the ongoing rate. Yucca Health runs $146/mo once promotional pricing ends, against $149/mo at Hers — a difference of 2%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Do Hers or Yucca Health take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Hers or Yucca Health?
Yucca Health, with 36,958 against 6,200. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Does Hers or Yucca Health offer tirzepatide?
Yucca Health does, at $258/mo. Hers publishes FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Hers and Yucca Health prescribe the same medication?
No. Hers dispenses brand-name, FDA-approved finished medication; Yucca Health dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
The verdict
Strictly on cost, Yucca Health takes it — $1,752 to $1,788 over twelve months.
The case for Hers is brand-name Wegovy at a price that usually buys compounded medication elsewhere. That is worth $3 a month to some patients and nothing at all to others — be honest about which you are.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Hers vs MaximusBrand-name vs compounded
- Hers vs He & She MDBrand-name vs compounded
- Yucca Health vs RefillsBudget vs premium
- Yucca Health vs EmbodyBudget vs premium
- Shed vs DirectmedsBrand-name vs compounded
- Shed vs WellorithmBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or Yucca Health, and does not sell treatment. Read our ranking methodology.